Literature DB >> 2564005

1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes.

D M Provvedini1, S C Manolagas.   

Abstract

Receptors for 1 alpha,25-dihydroxyvitamin D3 [1,25-(OH)2D3] are expressed upon activation of human lymphocytes, and the hormone inhibits in vitro the proliferation of mitogen-activated lymphocytes. In this study we examined the distribution of the 1,25-(OH)2D3 receptor protein in the two major subsets of T lymphocytes (T helper and T suppressor cells) and the effect of the hormone on their respective rates of proliferation. We activated normal lymphocytes in the presence of monocytes with phytohemagglutinin and subsequently isolated the T helper (T4-positive) and the T suppressor (T8-positive) subsets using monoclonal antibodies and complement-mediated lysis. In parallel experiments, we first isolated monocyte-depleted T4 and T8 cells and then activated them using phytohemagglutinin and a phorbol ester. Using either approach we found that both T4 and T8 lymphocytes expressed the 1,25-(OH)2D3 receptor protein upon activation. The concentration of this protein, its affinity for the ligand (Kd, approximately 10(-10) mol/L), and its sedimentation characteristics (S = 3.3) were indistinguishable in the two T cell subsets. Furthermore, the time kinetics of expression of the receptor after activation were very similar in the two subsets. Nevertheless, 1,25-(OH)2D3 inhibited in a dose-dependent fashion the rate of proliferation of the helper subset, but had no effect on the proliferation of suppressor cells. The finding of a dissimilar effect of 1,25-(OH)2D3 on the proliferation of the T helper and T suppressor cells despite their indistinguishable receptor status suggests that the 1,25-(OH)2D3 receptors of the T cells might not be involved in the effects of the hormone on T-cell proliferation, and that the 1,25-(OH)2D3-induced inhibition of mitogen-activated T4 cell proliferation could be mediated indirectly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564005     DOI: 10.1210/jcem-68-4-774

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.

Authors:  Tim Spelman; Orla Gray; Robyn Lucas; Helmut Butzkueven
Journal:  J Vis Exp       Date:  2015-12-09       Impact factor: 1.355

Review 3.  Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.

Authors:  Kelly C Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

4.  CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice.

Authors:  Terrence F Meehan; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

5.  Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages.

Authors:  L Overbergh; B Decallonne; D Valckx; A Verstuyf; J Depovere; J Laureys; O Rutgeerts; R Saint-Arnaud; R Bouillon; C Mathieu
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

6.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

Authors:  J M Lemire; D C Archer
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease.

Authors:  Maria Stio; Cristina Treves; Maria Martinesi; Giuseppe d'Albasio; Siro Bagnoli; Andrea G Bonanomi
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

8.  Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor.

Authors:  X P Yu; F G Hustmyer; W T Garvey; S C Manolagas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.

Authors:  C Mathieu; M Waer; J Laureys; O Rutgeerts; R Bouillon
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

10.  Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.

Authors:  Dashant Kavathia; John D Buckley; Dhanwada Rao; Benjamin Rybicki; Robert Burke
Journal:  Respir Med       Date:  2010-01-13       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.